Clinical Trial: A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07062185) titled 'A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)' on March 26.

Brief Summary: This is an open-label, single-arm, single-center study to evaluate the safety, pharmacokinetics, and efficacy signal of ENC1018 capsules in patients with moderate-to-severe active ulcerative colitis (UC).

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: ENC1018 capsule administration group

ENC1018 capsules were taken orally once a day for 14 days.

Recruitment Status: NOT_YET_RECR...